JUVENILE IDIOPATHIC ARTHRITIS (JIA)
Clinical trials for JUVENILE IDIOPATHIC ARTHRITIS (JIA) explained in plain language.
Never miss a new study
Get alerted when new JUVENILE IDIOPATHIC ARTHRITIS (JIA) trials appear
Sign up with your email to follow new studies for JUVENILE IDIOPATHIC ARTHRITIS (JIA), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a new pill ease arthritis in kids?
Disease control OngoingThis study is testing an oral medication called upadacitinib in children with polyarticular juvenile idiopathic arthritis (JIA), a condition causing joint inflammation. The goal is to understand how the drug moves through the body, its safety, and how well children tolerate it. P…
Matched conditions: JUVENILE IDIOPATHIC ARTHRITIS (JIA)
Phase: PHASE1 • Sponsor: AbbVie • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
Stem cell trial for kids with arthritis pulled before it started
Disease control TerminatedThis study was designed to test whether infusions of stem cells from donated fat tissue could safely improve symptoms of juvenile idiopathic arthritis in children aged 2 to 17. The trial was a phase 2, randomized, double-blind, placebo-controlled crossover study, but it was withd…
Matched conditions: JUVENILE IDIOPATHIC ARTHRITIS (JIA)
Phase: PHASE2 • Sponsor: Hope Biosciences Research Foundation • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC